Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25e744187ed64a39dc9788a7e206ce90 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728 |
filingDate |
2013-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e00ceddef74de5ed718a8c852d42bd1 |
publicationDate |
2016-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9433575-B1 |
titleOfInvention |
Method of administering hyaluronan formulation for preventing and ameliorating osteoarthritis |
abstract |
Disclosed is a method for mitigating or ameliorating osteoarthritis in vertebrate subjects including administering to a subject a therapeutically effective amount of an exogenous hyaluronan formulation. Also disclosed is an oral or parenteral hyaluronan composition comprising a polydisperse hyaluronan and a pharmaceutically acceptable carrier, and a method of manufacturing the composition. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10583153-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9993496-B1 |
priorityDate |
2005-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |